Applicability  ||| S:0 E:14 ||| NNP
of  ||| S:14 E:17 ||| IN
the  ||| S:17 E:21 ||| DT
SMART  ||| S:21 E:27 ||| NNP
Model  ||| S:27 E:33 ||| NNP
of  ||| S:33 E:36 ||| IN
Transition  ||| S:36 E:47 ||| NNP
Readiness  ||| S:47 E:57 ||| NNP
for  ||| S:57 E:61 ||| IN
Sickle-Cell  ||| S:61 E:73 ||| NNP
Disease  ||| S:73 E:81 ||| NNP
This  ||| S:81 E:86 ||| DT
study  ||| S:86 E:92 ||| NN
aimed  ||| S:92 E:98 ||| VBN
to  ||| S:98 E:101 ||| TO
examine  ||| S:101 E:109 ||| VB
the  ||| S:109 E:113 ||| DT
applicability  ||| S:113 E:127 ||| NN
of  ||| S:127 E:130 ||| IN
the  ||| S:130 E:134 ||| DT
Social-ecological  ||| S:134 E:152 ||| JJ
Model  ||| S:152 E:158 ||| NNP
of  ||| S:158 E:161 ||| IN
Adolescent  ||| S:161 E:172 ||| NNP
and  ||| S:172 E:176 ||| CC
Young  ||| S:176 E:182 ||| NNP
Adult  ||| S:182 E:188 ||| NNP
Readiness  ||| S:188 E:198 ||| NNP
to  ||| S:198 E:201 ||| TO
Transition  ||| S:201 E:212 ||| NNP
( ||| S:212 E:213 ||| -LRB-
SMART ||| S:213 E:218 ||| NNP
)  ||| S:218 E:220 ||| -RRB-
model  ||| S:220 E:226 ||| NN
for  ||| S:226 E:230 ||| IN
adolescents  ||| S:230 E:242 ||| NNS
and  ||| S:242 E:246 ||| CC
young  ||| S:246 E:252 ||| JJ
adults  ||| S:252 E:259 ||| NNS
( ||| S:259 E:260 ||| -LRB-
AYA ||| S:260 E:263 ||| NNP
)  ||| S:263 E:265 ||| -RRB-
with  ||| S:265 E:270 ||| IN
sickle-cell  ||| S:270 E:282 ||| JJ
disease  ||| S:282 E:290 ||| NN
( ||| S:290 E:291 ||| -LRB-
SCD ||| S:291 E:294 ||| NNP
) ||| S:294 E:295 ||| -RRB-
.   ||| S:295 E:298 ||| SYM
METHODS ||| S:298 E:305 ||| NNS
:   ||| S:305 E:308 ||| CD
14  ||| S:308 E:311 ||| CD
AYA  ||| S:311 E:315 ||| NN
with  ||| S:315 E:320 ||| IN
SCD  ||| S:320 E:324 ||| NNP
( ||| S:324 E:325 ||| -LRB-
14-24  ||| S:325 E:331 ||| CD
years  ||| S:331 E:337 ||| NNS
old ||| S:337 E:340 ||| JJ
)  ||| S:340 E:342 ||| -RRB-
and  ||| S:342 E:346 ||| CC
10  ||| S:346 E:349 ||| CD
clinical  ||| S:349 E:358 ||| JJ
experts  ||| S:358 E:366 ||| NNS
( ||| S:366 E:367 ||| -LRB-
6-20  ||| S:367 E:372 ||| CD
years  ||| S:372 E:378 ||| NNS
of  ||| S:378 E:381 ||| IN
experience ||| S:381 E:391 ||| NN
)  ||| S:391 E:393 ||| -RRB-
completed  ||| S:393 E:403 ||| VBD
semi-structured  ||| S:403 E:419 ||| JJ
interviews ||| S:419 E:429 ||| NNS
.  ||| S:429 E:431 ||| .
AYA  ||| S:431 E:435 ||| NNP
completed  ||| S:435 E:445 ||| VBD
brief  ||| S:445 E:451 ||| JJ
questionnaires ||| S:451 E:465 ||| NN
.  ||| S:465 E:467 ||| .
Interviews  ||| S:467 E:478 ||| NNS
were  ||| S:478 E:483 ||| VBD
coded  ||| S:483 E:489 ||| VBN
for  ||| S:489 E:493 ||| IN
themes ||| S:493 E:499 ||| NNS
,  ||| S:499 E:501 ||| ,
which  ||| S:501 E:507 ||| WDT
were  ||| S:507 E:512 ||| VBD
reviewed  ||| S:512 E:521 ||| VBN
to  ||| S:521 E:524 ||| TO
determine  ||| S:524 E:534 ||| VB
their  ||| S:534 E:540 ||| PRP$
fit  ||| S:540 E:544 ||| NN
within  ||| S:544 E:551 ||| IN
the  ||| S:551 E:555 ||| DT
SMART  ||| S:555 E:561 ||| FW
model ||| S:561 E:566 ||| FW
.   ||| S:566 E:569 ||| FW
RESULTS ||| S:569 E:576 ||| NNS
:   ||| S:576 E:579 ||| VBP
Overall ||| S:579 E:586 ||| RB
,  ||| S:586 E:588 ||| ,
most  ||| S:588 E:593 ||| JJS
themes  ||| S:593 E:600 ||| NNS
were  ||| S:600 E:605 ||| VBD
consistent  ||| S:605 E:616 ||| JJ
with  ||| S:616 E:621 ||| IN
the  ||| S:621 E:625 ||| DT
model  ||| S:625 E:631 ||| NN
( ||| S:631 E:632 ||| -LRB-
e.g. ||| S:632 E:636 ||| NNP
,  ||| S:636 E:638 ||| ,
sociodemographics ||| S:638 E:655 ||| CD
/ ||| S:655 E:656 ||| CD
culture ||| S:656 E:663 ||| NN
,  ||| S:663 E:665 ||| ,
neurocognition ||| S:665 E:679 ||| VBG
/ ||| S:679 E:680 ||| NNP
IQ ||| S:680 E:682 ||| NNP
,  ||| S:682 E:684 ||| ,
etc. ||| S:684 E:688 ||| FW
) ||| S:688 E:689 ||| -RRB-
.  ||| S:689 E:691 ||| .
Factors  ||| S:691 E:699 ||| NNS
related  ||| S:699 E:707 ||| VBN
to  ||| S:707 E:710 ||| TO
race ||| S:710 E:714 ||| CD
/ ||| S:714 E:715 ||| CD
culture ||| S:715 E:722 ||| NN
,  ||| S:722 E:724 ||| ,
pain  ||| S:724 E:729 ||| NN
management ||| S:729 E:739 ||| NN
,  ||| S:739 E:741 ||| ,
health-care  ||| S:741 E:753 ||| JJ
navigation  ||| S:753 E:764 ||| NN
skills ||| S:764 E:770 ||| NNS
,  ||| S:770 E:772 ||| ,
societal  ||| S:772 E:781 ||| JJ
stigma ||| S:781 E:787 ||| NN
,  ||| S:787 E:789 ||| ,
and  ||| S:789 E:793 ||| CC
lack  ||| S:793 E:798 ||| NN
of  ||| S:798 E:801 ||| IN
awareness  ||| S:801 E:811 ||| NN
about  ||| S:811 E:817 ||| IN
SCD  ||| S:817 E:821 ||| NNP
were  ||| S:821 E:826 ||| VBD
salient  ||| S:826 E:834 ||| VBN
for  ||| S:834 E:838 ||| IN
AYA  ||| S:838 E:842 ||| NNP
with  ||| S:842 E:847 ||| IN
SCD ||| S:847 E:850 ||| NNP
.   ||| S:850 E:853 ||| FW
CONCLUSIONS ||| S:853 E:864 ||| NNP
:   ||| S:864 E:867 ||| NNP
Findings  ||| S:867 E:876 ||| NNPS
suggest  ||| S:876 E:884 ||| VBP
the  ||| S:884 E:888 ||| DT
SMART  ||| S:888 E:894 ||| NNP
model  ||| S:894 E:900 ||| NN
may  ||| S:900 E:904 ||| MD
be  ||| S:904 E:907 ||| VB
appropriate  ||| S:907 E:919 ||| JJ
in  ||| S:919 E:922 ||| IN
SCD  ||| S:922 E:926 ||| NNP
with  ||| S:926 E:931 ||| IN
the  ||| S:931 E:935 ||| DT
consideration  ||| S:935 E:949 ||| NN
of  ||| S:949 E:952 ||| IN
disease-related  ||| S:952 E:968 ||| JJ
stigma ||| S:968 E:974 ||| NN
.  ||| S:974 E:976 ||| .
This  ||| S:976 E:981 ||| DT
study  ||| S:981 E:987 ||| NN
is  ||| S:987 E:990 ||| VBZ
a  ||| S:990 E:992 ||| DT
step  ||| S:992 E:997 ||| NN
toward  ||| S:997 E:1004 ||| IN
developing  ||| S:1004 E:1015 ||| VBG
a  ||| S:1015 E:1017 ||| DT
disease-specific  ||| S:1017 E:1034 ||| JJ
model  ||| S:1034 E:1040 ||| NN
of  ||| S:1040 E:1043 ||| IN
transition  ||| S:1043 E:1054 ||| NN
readiness  ||| S:1054 E:1064 ||| NN
for  ||| S:1064 E:1068 ||| IN
SCD ||| S:1068 E:1071 ||| NNP
.  ||| S:1071 E:1073 ||| .
Future  ||| S:1073 E:1080 ||| JJ
directions  ||| S:1080 E:1091 ||| NNS
include  ||| S:1091 E:1099 ||| VBP
the  ||| S:1099 E:1103 ||| DT
development  ||| S:1103 E:1115 ||| NN
of  ||| S:1115 E:1118 ||| IN
a  ||| S:1118 E:1120 ||| DT
measure  ||| S:1120 E:1128 ||| NN
of  ||| S:1128 E:1131 ||| IN
transition  ||| S:1131 E:1142 ||| NN
readiness  ||| S:1142 E:1152 ||| NN
for  ||| S:1152 E:1156 ||| IN
this  ||| S:1156 E:1161 ||| DT
population ||| S:1161 E:1171 ||| NN
.  ||| S:1171 E:1173 ||| .
